Healthcare & Pharma • Quantitative Market Data & AI Analytics
| Metric / Indicator | Current Reading | AI Action Verdict |
|---|---|---|
| RSI (14) Relative Strength | 44.78 | 🔒 Unlock AI Verdict |
| MACD (12, 26, 9) Level / Signal | -1.124 / -1.120 | 🔒 Unlock AI Verdict |
| Bollinger Bands (20, 2) & EMA (50/200) | 68.90 - 74.64 | BULLISH TREND |
| AI News Sentiment & Momentum Score | 82.5 / 100 | High Accumulation |
| AI Hybrid Probability & 30D Target Range | 67.46 - 80.38 | STRONG BUY |
You are viewing raw mathematical RSI (44.8) and MACD (-1.124) computations. To unlock AI interpretation, Bullish/Bearish ratings, Bollinger Bands, Executive Insider Trades, and 30-Day Statistical Trend Charts for Sanofi, download the TradeGPT Android app.
Download on Google Play
Sanofi S.A. is a French multinational pharmaceutical company and one of the world's leading healthcare providers. The company focuses on four primary business units: Specialty Care (immunology, oncology, rare diseases), Vaccines, General Medicine, and Consumer Healthcare. Sanofi's flagship product, Dupixent, has become a global leader in treating inflammatory conditions. The company is currently undergoing a strategic transformation named "Play to Win," which involves reallocating capital toward innovative R&D, particularly in mRNA technology and immunology, while divesting from some of its non-core consumer health assets. Sanofi maintains a massive global manufacturing footprint and is a critical player in global public health initiatives. Its headquarters are in Paris, France.
Read more Google Play
